This webinar is jointly organized by Labcorp Drug Development and Median Technologies. New Imaging biomarkers have a strong potential to provide additional insight for clinical trials: better selection of patients, prediction of response to therapy, early assessments of drug effects and safety. However, implementing them in clinical trials often promote challenges. The aim of this webinar is to discuss these challenges from the perspective of patients, physicians and the different stakeholders involved in the oncology clinical trials. During this webinar, you will learn:
- The value of modern imaging technologies in oncology trials
- The challenges linked to implementation of new imaging biomarkers
- How AI powered imaging optimizes clinical trial design
- Dr Yumin Zhang, Vice President and Chief Medical Officer, Huayi Technology CO LTD
- Dr Ravi Karra, M.D, Senior Medical Director Oncology, Labcorp Drug Development
- Dr Yan Liu, Chief Medical Officer, Median Technologies.